Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending July 19, 2016. The document serves as a transaction notification regarding a Person Discharging Managerial Responsibilities (PDMR) rather than a financial results report.
Key Financial Metrics
The filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity. It exclusively details a specific securities transaction involving American Depositary Shares (ADSs).
Material Changes
The filing reports an increase in the notional interest in GSK ADSs held by Dr. M M Slaoui, Chairman of Global Vaccines. This increase resulted from the re-investment of dividends paid to shareholders on July 14, 2016, under the Company's 2009 Performance Share Plan.
Transaction Details
- Instrument: American Depositary Shares (ADSs), ISIN: US37733W1053
- Transaction Date: July 14, 2016
- Transaction Price: $43.87 per ADS
- Aggregated Volume: 4,902.436 ADSs
- Nature: Dividend re-investment
Investor Verification Points
- Verify the total number of ADSs held by Dr. M M Slaoui following this transaction to assess total exposure.
- Confirm the terms of the 2009 Performance Share Plan regarding dividend re-investment mechanics.
- Note that this filing contains no operational or financial performance data for the quarter or year.